[1]
Abston, E. et al. 2020. Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertensio. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 37, 2 (Jun. 2020), 184–191. DOI:https://doi.org/10.36141/svdld.v37i2.9150.